Jill Andersen
Consejero General en INVIVYD, INC. .
Fortuna: 5 589 $ al 30/04/2024
Cargos activos de Jill Andersen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INVIVYD, INC. | Consejero General | 22/11/2021 | - |
| Secretario Corporativo | - | - |
Historial de carrera de Jill Andersen
Antiguos cargos conocidos de Jill Andersen.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Consejero General | 01/09/2016 | 01/05/2020 |
| CELGENE | Consejero General | 01/09/2016 | 01/05/2020 |
| Novartis Services, Inc. | Consejero General | 01/03/2015 | 01/09/2016 |
Davis Polk & Wardwell LLP
 Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1994 | 01/01/1996 |
| OYSR POIN | Oficial de Cumplimiento | - | - |
| Consejero General | 01/06/2020 | 01/10/2021 | |
| Secretario Corporativo | - | - |
Formación de Jill Andersen.
| Boston College | Undergraduate Degree |
| Wake Forest University School of Law | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
Operativa
| General Counsel | 5 |
| Corporate Secretary | 2 |
| Compliance Officer | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| INVIVYD, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
Davis Polk & Wardwell LLP
Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Commercial Services |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| Novartis Services, Inc. |
- Bolsa de valores
- Insiders
- Jill Andersen
- Experiencia
